Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

• Chenghao Fu,
• Chenghao Fu,
• Haonan Du,
• Qiang Wang,
• Weiyou Zhu,
• Guangli Bian,
• Zhujuan Zhong,
• Yuheng Wang,
• Lei Cao

Affiliations

Chenghao Fu

Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Chenghao Fu

Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Haonan Du

Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Qiang Wang

Department of Thoracic Surgery, Taizhou Fourth People’s Hospital, Taizhou, Jiangsu, China

Weiyou Zhu

Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Guangli Bian

Department of Radiology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, China

Zhujuan Zhong

Department of Pathology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, China

Yuheng Wang

Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Lei Cao

Department of Oncology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, China